• Return to Headlines

Qiagen Nv: 52-Week High Recently Eclipsed (QGEN)

By Shiri Gupta

Qiagen Nv (NYSE:QGEN) traded today at a new 52-week high of $40.14. So far today approximately 195,000 shares have been exchanged, as compared to an average 30-day volume of 1.5 million shares.

Qiagen Nv share prices have moved between a 52-week high of $40.14 and a 52-week low of $0.00 and are now trading -100% above that low price at $40.14 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 1.2%.

Qiagen Nv (NYSE:QGEN) is currently priced 10.6% above its average consensus analyst price target of $35.87. The stock should discover initial support at its 50-day moving average (MA) of $37.47 and subsequent support at its 200-day MA of $36.65.

QIAGEN N.V. is a global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. The Company provides its workflows to customers in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research).

SmarTrend recommended that subscribers consider buying shares of Qiagen Nv on January 4th, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $34.73. Since that recommendation, shares of Qiagen Nv have risen 14.6%. We continue to monitor QGEN for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows qiagen nv

Ticker(s): QGEN